NYSE$CAH
Cardinal Health Inc · Q2 2020 earnings
Q2 2020 earnings · · Investor relations
Briefing
Cardinal Health announced voluntary field actions for select procedure packs containing affected surgical gowns.
Cardinal Health initiated two voluntary field actions for select Cardinal Health Presource® Procedure Packs containing gowns due to concerns over sterility from an unapproved supplier. The company expects to record a $96 million charge in the second quarter of fiscal year 2020 related to these recalls.
- Initiated voluntary correction of 374,794 procedure packs with components separated from the affected gown.
- Initiated a voluntary recall of 2,518,653 procedure packs containing gowns with components not separated from the affected gown.
- Terminated relationship with Siyang Holymed due to shifted production to unapproved sites.
- Expects to record a $96 million charge in the second quarter of fiscal year 2020 related to the recalls.
Headline financials
Revenue & EPS history
Cardinal Health · Revenue · Quarterly
$39.7B
Forward guidance
Cardinal Health expects to record a $96 million charge in the second quarter of fiscal year 2020 related to surgical gown-related recalls.
Tailwinds
- Increasing its manufacturing production of similar and replacement products.
- Offering more protective AAMI Level 4 gowns to help bridge the supply gap.
- Working to identify alternatives - including in many cases working with industry partners who offer comparable products.
- Mobilizing employees from all parts of the company to work directly with health care providers to replace gowns and procedure packs.
Headwinds
- Current and future costs associated with the recalls of surgical gowns and related kits could have a material negative impact on financial results.
- Risk of losing sales and customers due to the recalls.
- Recalls could lead to actions by regulators or other governmental entities.
- May receive claims and lawsuits by customers and patients, including class action product liability lawsuits.
- Recalls and related operational impacts could have unintended consequences, such as business disruption and distraction of management and other key employees.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q2 2020
+0.2%
Avg return
Earnings day
+0.4%
Avg return
5 days after
+1.6%
Avg return
30 days after
58%
41 / 71 earnings
Positive
+15.3%
Q1 2026
Best reaction
-18.0%
Q3 2018
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q3 2026 | +0.0% | -2.9% | -3.1% | |
| Q2 2026 | +9.8% | +6.5% | +5.3% | |
| Q1 2026 | +15.3% | +18.8% | +29.1% | |
| Q3 2025 | +3.0% | +7.4% | +9.3% | |
| Q2 2025 | +0.4% | -2.0% | +1.3% | |
| Q1 2025 | +3.1% | +6.5% | +12.6% | |
| Q4 2024 | +5.2% | +7.0% | +10.3% | |
| Q3 2024 | -3.2% | -2.4% | -2.8% | |
| Q2 2024 | -5.2% | -4.7% | +3.8% | |
| Q1 2024 | +8.4% | +9.1% | +14.3% | |
| Q4 2023 | -2.8% | -7.7% | -5.7% | |
| Q3 2023 | +1.9% | +3.3% | +3.6% | |
| Q2 2023 | +3.9% | +3.8% | -0.7% | |
| Q1 2023 | +7.0% | +5.9% | +6.9% | |
| Q4 2022 | +10.5% | +11.8% | +11.4% | |
| Q3 2022 | -3.7% | -7.3% | -11.0% | |
| Q2 2022 | +0.7% | +4.9% | +4.7% | |
| Q1 2022 | +1.3% | +3.6% | -2.3% | |
| Q4 2021 | -13.5% | -13.5% | -9.1% | |
| Q3 2021 | -4.4% | -7.7% | -7.0% | |
| Q2 2021 | -5.5% | -5.2% | -4.4% | |
| Q1 2021 | +6.5% | +16.0% | +15.3% | |
| Q4 2020 | -8.7% | -7.9% | -13.7% | |
| Q3 2020 | +0.4% | -1.9% | +11.2% | |
| Q2 2020 | -4.7% | -4.0% | -3.0% | |
| Q1 2020 | +4.5% | +5.1% | +6.7% | |
| Q4 2019 | +3.7% | +4.5% | +6.3% | |
| Q3 2019 | -1.7% | -7.3% | -11.8% | |
| Q2 2019 | +3.7% | +7.4% | -6.1% | |
| Q1 2019 | +3.1% | +5.7% | +0.5% | |
| Q4 2018 | +1.0% | -3.8% | +4.1% | |
| Q3 2018 | -18.0% | -18.8% | -18.5% | |
| Q2 2018 | +2.4% | +0.8% | +9.2% | |
| Q1 2018 | -1.8% | -4.6% | -2.7% | |
| Q4 2017 | -10.3% | -10.5% | -12.3% | |
| Q3 2017 | +0.6% | -0.2% | +2.3% | |
| Q2 2017 | +2.4% | +1.9% | +7.9% | |
| Q1 2017 | -0.9% | -3.5% | +5.2% | |
| Q4 2016 | +2.7% | +2.4% | -3.3% | |
| Q3 2016 | -9.3% | — | — | |
| Q2 2016 | -4.5% | — | — | |
| Q1 2016 | +5.1% | — | — | |
| Q4 2015 | +0.7% | — | — | |
| Q3 2015 | -3.8% | — | — | |
| Q2 2015 | -2.6% | — | — | |
| Q1 2015 | +0.5% | — | — | |
| Q4 2014 | -2.3% | — | — | |
| Q3 2014 | -8.2% | — | — | |
| Q2 2014 | +2.4% | — | — | |
| Q1 2014 | +8.2% | — | — | |
| Q4 2013 | +2.0% | — | — | |
| Q3 2013 | +5.6% | — | — | |
| Q2 2013 | +1.2% | — | — | |
| Q1 2013 | +2.5% | — | — | |
| Q4 2012 | -7.7% | — | — | |
| Q3 2012 | -0.8% | — | — | |
| Q2 2012 | -2.4% | — | — | |
| Q1 2012 | +3.1% | — | — | |
| Q4 2011 | +4.5% | — | — | |
| Q3 2011 | +1.5% | — | — | |
| Q2 2011 | -0.8% | — | — | |
| Q1 2011 | -0.9% | — | — | |
| Q4 2008 | +2.4% | — | — | |
| Q4 2010 | +2.4% | — | — | |
| Q4 2009 | +2.4% | — | — | |
| Q3 2010 | -5.6% | — | — | |
| Q3 2009 | -5.6% | — | — | |
| Q2 2010 | -1.0% | — | — | |
| Q2 2009 | -1.0% | — | — | |
| Q1 2010 | +2.7% | — | — | |
| Q1 2009 | +2.7% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro